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ABSTRACT Type IV pili of Neisseria gonorrhoeae, the Gram-
negative etiologic agent of gonorrhea, facilitate colonization of
the human host. Gonococcal PilT, a protein belonging to a large
family of molecules sharing a highly conserved nucleotide bind-
ing domain motif, has been shown to be dispensable for organelle
biogenesis but essential for twitching motility and competence
for genetic transformation. Here, we show that the defect in pilus
biogenesis resulting from mutations in the pilC gene, encoding a
putative pilus-associated adhesin for human tissue, can be
suppressed by the absence of functional PilT. These data con-
clusively demonstrate that PilT influences the Type IV pilus
biogenesis pathway and strongly suggest that organelle expres-
sion is a dynamic process. In addition, these findings imply that
PilT antagonizes the process of organelle biogenesis and provide
the basis for a model for how the counteractive roles of PilT and
PilC might relate mechanistically to the phenomenon of twitch-
ing motility.
The adherence of pathogenic bacteria to mammalian tissue
represents a crucial step in the pathogenesis of infections with the
specificity of adhesin–receptor interactions defining host range
and tissue tropism. In virtually all Gram-negative pathogens that
colonize mucosal surfaces, attachment is mediated by supramo-
lecular polymeric fibers termed pili or fimbriae (1).
Many bacterial pathogens, including Neisseria gonorrhoeae,
Neisseria meningitidis, enteropathogenic E. coli, Vibrio cholerae,
Moraxella bovis, Pseudomonas aeruginosa, and Dichelobacter no-
dosus, express the Type IV pilus colonization factor. These pili
share structural, biochemical, antigenic, and functional features
(2). In addition, the prepilin subunits of Type IV pili (Tfp) display
a high degree of identity to each other within the N terminus, the
domain that functions in inner membrane insertion and proteo-
lytic processing and is predicted to form the central helical core
of the pilus filament (3). Further evidence for the relatedness of
these organelles can be found in the conservation of genes and
gene products required for their biogenesis. These include prepi-
lin peptidases, soluble proteins with essential nucleotide-binding
motifs, polytopic inner membrane proteins, and a family of outer
membrane proteins that appear to function as gated channels or
pores through which pili are extruded (4). Homologues of some
Tfp biogenesis machinery components have been shown to be
required for secretion of toxins and hydrolases by Gram-negative
bacteria (5), competence for transformation in Bacillus subtilis
(6), and filamentous phage morphogenesis (7). Therefore, it
appears that these elements are part of a highly conserved
pathway for membrane translocation of macromolecules. How-
ever, with the exception of the prepilin peptidases (8), the precise
functions of these conserved components remain unknown.
Gonococcal Tfp appear to play an important role in promoting
adherence to mucosal epithelial cells, a crucial step in coloniza-
tion of the human host (9). This function requires the simulta-
neous expression of pili and the outer membrane protein PilC,
which originally was identified by virtue of its presence in pilus
preparations (10, 11). Although nonpiliated, PilC1 mutants fail to
adhere, PilC appears to be the adhesive moiety of gonococcal pili
because purified PilC binds specifically to cells of human origin
and can competitively block the adherence of piliated gonococci
(12). Attempts at isolating piliated, PilC2 mutants to confirm this
have been complicated because PilC is required for organelle
biogenesis (10).
In addition to their role in adherence, gonococcal Tfp are
required for a novel mode of flagella-independent surface trans-
location known as twitching motility (13, 14). Tfp-associated
motility also is found in P. aeruginosa as well as in Myxococcus
xanthus, where it is manifest as social gliding motility (15, 16). The
exact role of Tfp in this phenomenon has yet to be elucidated.
Mutations in the highly conserved pilT gene lead to a piliated but
nonmotile phenotype in each of these three species (17–19). PilT
proteins are members of a large family of putative nucleotide
binding proteins (TrbB-like proteins) that are involved in mem-
brane translocation of macromolecules in prokaryotes (20). Phy-
logenetic analysis has shown that PilT proteins are most similar
to the other TrbB-like family members required for Tfp biogen-
esis (M.K., unpublished data). In addition, the M. xanthus pilT
gene is clustered with other genes whose products are required for
Tfp biogenesis (17). It seemed plausible then that PilT proteins
influence the Tfp biogenesis pathway. However, no alterations in
Tfp structure, morphology, or expression have been noted in any
of the paralyzed pilT mutants except in P. aeruginosa, in which
mutants have been found to be hyperpiliated (17–19). These
findings prompted us to examine whether gonococcal mutants
lacking both PilT and PilC, a known Tfp biogenesis component,
might display unique phenotypes.
Here we show that PilT influences the Tfp biogenesis pathway.
We discovered that loss of function mutations in pilT alleviate the
requirement for PilC in pilus biogenesis. This result implies that
PilT antagonizes the biogenesis process, consistent with its po-
tential role in organelle retraction or destabilization. This finding
also made it possible to characterize genetically defined mutants
that express Tfp in the absence of PilC. We demonstrate that
these mutants are incapable of adhering to human epithelial
tissue.
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Bacterial Strains and Plasmids. The bacterial strains used in
this study are described in Table 1. E. coli and gonococcal strains
were grown as described (21). Gonococcal strain N401 was
created by replacing the isopropyl b-D-thiogalactopyranoside
(IPTG)-inducible recA allele (recA6) linked marker (tetM) in
strain N400 (21) with a kanamycin resistance gene. This was
accomplished by replacing the SacI fragment of pVD300recA6
(22) with a HincII fragment from pUCKan (accession no.
X06404) containing the kanamycin resistance gene to yield
pVD300recA6(Kan). This plasmid then was used to transform
strain N400. Transformants were selected for resistance to kana-
mycin (50 mgyml) and sensitivity to tetracycline (4 mgyml). The
pilT-inducible strain MW4 was created by transforming N401
with placP-PilT as described (18).
pilC null alleles were generated by PCR amplification of
internal fragments of each gene. pilC1 was amplified by using
primers AJM.C1.589F (59-CGAATTCAGACGGCGACCTCAT-
CCTTGCTTCCATTCAG) and AJM.C1.1672B (59-CGAATT-
CAGACGGCTATACGCACAGAACAGGAGCAGGCTC).
Primers contained gonococcal DNA uptake sequences (bold)
and flanking EcoRI restriction sites (italicized). The product
spans nucleotides 589-1672 of pilC1 (accession no. Z50180). A
fragment of pilC2 was amplified by using primers AJM.C2.262F
(59-GAATTCAGACGGCATACGAGCCAGAGAAACTGGA-
AC) and AJM.C2.1581B (59-GAATTCAGACGGCTTCTTTTG-
TGCGGATGCGG). The pilC2 product spans nucleotides 262-
1581 (accession no. Z49120). The PCR fragments were cloned
into the EcoRI site of pUC19. An internal EcoRV fragment in
pilC1 (nucleotides 1034–1188) was replaced with a fragment
carrying an erythromycin resistance gene to yield pSPAM2. The
same approach was used to replace an internal EcoRV fragment
of pilC2 (nucleotides 722-1266) with a chloramphenicol acetyl-
transferase gene cassette to produce pSPAM3. The wild-type
gonococcal strain N400 and the pilT-inducible strain MW4 were
transformed with pSPAM2 andyor pSPAM3 and were selected
on the appropriate antibiotics to generate the pilC null strains
described in Table 1.
SDSyPAGE, Immunoblotting, and Staining. Procedures for
SDSyPAGE and immunoblotting have been described (23). PilE
and PilC were detected by immunoblotting pilus preps and whole
cell lysates by using rabbit polyclonal antibodies and alkaline
phosphatase coupled goat anti-rabbit antibodies (Tago). PilC
specific sera was a gift of A.-B. Jonsson (Karolinska Institute,
Stockholm). PilE specific sera (lot 2–66) was described (24). The
pilin subunit from purified pili was detected by Coomassie
staining of SDSyPAGE gels. Pilus purification was carried out as
described (18).
Protein Quantitation. Total cellular protein was extracted by
resuspending gonococcal cell pellets in lysis buffer (0.2 M potas-
sium phosphate buffer, pH 7.5y20% acetoney40 mM EDTAy
0.1% Triton X-100) and incubating on ice for 15 min. Protein
concentration was determined by using the Bio-Rad Protein
Assay and BSA standards according to the manufacturer’s in-
structions.
DNA Sequencing. Fragments containing the poly G stretch of
pilC1 and pilC2 were PCR amplified by using Vent DNA poly-
merase and primers PilC1–59 (59-ACTTTGAAACGGCAGG-
TTTTCCGC), PilC1–39 (59-ATTCTGCTTTACCTCGGGCT-
GGTT), PilC2–59 (59-AACTTTAAAAAGGCGGGTTTTCC-
GC), and PilC2–39 (59-TTTCTCTGGCTCGTATGGCTAAA-
TG). PCR products were sequenced by using the Thermo
Sequenase radiolabeled terminator cycle sequencing kit (Amer-
sham) according to the manufacturer’s protocol.
Epithelial Cell Adherence Assay. Primary cultures of human
corneal epithelial cells were established as described (25). For use
in adherence assays, epithelial cells were grown on 12-mm circular
glass or thermanox coverslips in 1 ml of medium. Before the start
of the infection, the medium was replaced with 1 ml DMEM
supplemented with 5% fetal calf serum. Gonococci were sus-
pended in tissue culture medium and were added to the cells (2 3
107 per well). When appropriate, IPTG was present during the
assay. After 1 h incubation (37°C, 10% CO2), the infection was
stopped by rinsing the cells three times with 1 ml of Dulbecco’s
PBS to remove unbound bacteria, followed by fixation (at least 30
min at room temperature) in 0.1% glutaraldehydey1% parafor-
maldehyde in Dulbecco’s PBS. Specimens were stained with
crystal violet (0.007% in distilled water), and bacterial adherence
was scored with an Olympus (New Hyde Park, NY) BH-2
microscope.
Electron Microscopy. Colonies of bacteria grown on GC agar
plates for 12 h were touched gently with pioloform-coated grids
and were air-dried. Grids subsequently were stained with 1%
ammonium molybdate in water for 2 min, were rinsed once with
water, were air-dried, and were viewed in a Hitachi (Tokyo)
HU-11E-1 electron microscope.
RESULTS
An Assay To Examine the Potential Influence of PilT on Tfp
Biogenesis. Because PilT molecules are closely related to other
proteins within the TrbB-like family that are essential for Tfp
biogenesis, we theorized that new insights into PilT function
Table 1. Genotype and phenotype of N. gonorrhoeae strains used in this study
Strain
Parent
strain Relevant genotype Piliation* Adherence† Reference
N400 VD300 recA6(tetM)‡ 11 111 24
N401 N400 recA6(kan) 11 111 This study
MW1 N400 pilC1::erm 11 111 This study
MW2 N400 pilC2::cat 1 1 This study
MW3 MW1 pilC1::erm, pilC2::cat 2 2 This study
MW4 N401 pilTind 11 111 This study
MW5 MW4 pilTind, pilC1::erm 11 111 This study
MW6 MW4 pilTind, pilC2::cat 11 1 This study
MW7 MW5 pilTind, pilC1::erm, pilC2::cat 11 2 This study
GT101 N400 pilTdud1 11 111 18
MW8 GT101 pilTdud1, pilC2off 11 1 This study
GT102 N400 pilTDQSL 11 111 18
MW9 GT102 pilTDQSL, pilC2? 11 1 This study
MW10 GT102 pilTDQSL, pilC2off 11 1 This study
*Piliation was accessed by transmission electron microscopy: 2, ,1 pilusydiplococci; 1, 1–5 piliybacterial cell; 11, .10
piliybacterial cell.
†Adherence was determined by the average number of bacterial cells associated with each primary human corneal epithelial
cell: 2, ,0.1 bacteriumyepithelial cell; 1, 1–10 bacteriayepithelial cell; 111, .100 bacteriayepithelial cell.
‡recA6 is an IPTG-inducible allele of recA.























might be gained from studying mutants that carry both pilT
mutations and lesions in genes whose products are essential for
Tfp expression. Both nonpiliated and PilT mutants are nontrans-
formable owing to defects at the level of DNA uptake (18), a
situation that made it problematic to construct double mutants by
standard allelic replacement methods. As a means to circumvent-
ing this obstacle, we used the strain MW4, which carries the pilT
gene under control of an inducible promoter. In the absence of
induction, no detectable PilT is produced whereas addition of the
inducer (IPTG) leads to gene expression and wild-type Tfp-
associated phenotypes (18). In this background, mutations in
biogenesis genes could be introduced into the genome by trans-
formation after transient pilT expression.
Lack of Transcription of pilT Suppresses the Biogenesis Defect
in pilC Mutants. Mutants that fail to express intact PilC have been
reported to have dramatically reduced levels of Tfp (10). The
gonococcal genome contains two complete, unlinked alleles of
pilC whose expression is phase-variable owing to frameshifting
within a poly G stretch early in their ORFs. To assess the
influence of PilC on Tfp biogenesis in the parental strain N400,
inactivated alleles of pilC1 and pilC2 (containing deletions in the
pilC ORFs in conjunction with the insertion of selectable gene
markers) were introduced by transformation. Strain MW1, which
carries a disruption of pilC1, was phenotypically wild-type (Fig.
1B) whereas inactivation of pilC2 (strain MW2) yielded cells that
were phenotypically nonpiliated (Fig. 1C). Sequencing of the poly
G stretches within both genes confirmed that the pilC1 allele is
out-of-frame (12 G residues) whereas that of pilC2 is in-frame (13
G residues). These findings demonstrate that the strains used here
express PilC from the pilC2 allele whereas the pilC1 allele is in a
phase-off configuration, confirming similar findings made in
previous studies of related strains (10, 11).
Soluble, truncated forms of pilin (termed S-pilin) lacking the
first 40 residues of the mature protein are seen in all Tfp
biogenesis mutants characterized by our group (4). This altered
processing of pilin appears to be a consequence of a disrupted
biogenesis pathway, and although its precise basis is not clear, its
presence provides a sensitive marker for reduced or disrupted Tfp
expression. Consistent with their defect in Tfp expression, strain
MW2 carrying the defective pilC2 allele produced S-pilin (data
not shown). However, when examined by electron microscopy,
these cells expressed low levels of pili, with '10% of cells
exhibiting one or more pilus filaments (Fig. 2D). Piliation in this
background, albeit reduced, was confirmed by the ability to
recover low amounts of pili by a standard purification scheme
(Fig. 3, lane 3). To assess the basis for residual pilus expression in
this background, strain MW3 was constructed in which both
alleles of pilC were disrupted. This strain was phenotypically
nonpiliated (Fig. 1D), and no pili were detected by purification
(Fig. 3, lane 4) or by electron microscopic examination (data not
shown) whereas S-pilin was readily detectable (Fig. 4, lane 2).
We then examined the influence of these same pilC mutations
in strain MW4, the background in which pilT transcription was
repressed. Strain MW5, created by introduction of the pilC1
knockout mutation, was phenotypically indistinguishable from its
parent (Fig. 1 E and F and Table 1). In contrast, introduction of
the inactivated pilC2 allele into MW4 (creating MW6) yielded
transformants with colony morphologies normally representative
of highly piliated variants but slightly different from that found for
the parental strain (Fig. 1G). These pilC mutants expressed levels
of Tfp as high, if not higher, than that found for N400 or MW4.
In addition, the gross morphology of the pilus fibers was indis-
tinguishable from those seen in the other parental strains (data
not shown). Immunoblotting revealed that the pilin present in
these mutants was not processed detectably into S-pilin (data not
shown). Given the possibility that a product derived from the
out-of-frame pilC1 allele might contribute to Tfp biogenesis, a
derivative of MW5 was constructed in which both pilC alleles
were disrupted, giving rise to strain MW7. As found for the pilC2
knockout mutant in this background, this mutant had a piliated
colony morphology (Fig. 1H), showed high levels of piliation by
electron microscopy (Fig. 2E), and did not express S-pilin (Fig. 4,
lane 6).
Next, we assessed the relative levels of Tfp and the status of
putative Tfp-associated proteins in these strains. For this purpose,
Tfp were purified from the isogenic derivatives and were exam-
ined after SDSyPAGE by protein staining and immunoblotting
(Fig. 3). In all cases, the migrations of pilins in these backgrounds
were identical to one another, although the relative abundance of
pilin was reduced in strains MW4 and MW5 (Fig. 3, lanes 5 and
6). Reduction in pilin found for these strains did not reflect a
diminution of Tfp levels because electron microscopy does not
reveal discernible differences between wild-type and pilT mu-
tants. Rather, it appears to represent the propensity of Tfp from
pilT mutants to pellet during the centrifugation step used to
remove whole cells after shearing off of pili (unpublished data).
Coomassie stained protein profiles of pili isolated from MW6 and
MW7, the PilC-lacking derivatives of MW4, were identical to that
of the other strains save for the absence of a 110-kDa protein
(data not shown). Immunoblotting demonstrated that this mol-
ecule was PilC and also revealed that the pili from MW6
(pilC2::cat) contained low levels of reactive material (Fig. 3, lane
7) that was shown to be derived from the pilC1 allele (Fig. 3, lane
8). These findings established that gonococcal Tfp can be ex-
pressed at high levels in the absence of PilC, providing that
transcription of pilT is abolished.
FIG. 1. Contributions of pilC and pilT to Tfp expression as assessed by colony morphologies, a readout of pilus-dependent autoagglutination.
Colonies were photographed after 24 h of growth on Gc agar plates at a magnification of 703 using a stereomicroscope. (A) N400 (wild-type).
(B) MW1 (pilC1::erm). (C) MW2 (pilC2::cat). (D) MW3 (pilC1::erm, pilC2::cat). (E) MW4 (pilTind). (F) MW5 (pilTind, pilC1::erm). (G) MW6
(pilTind, pilC2::cat). (H) MW7 (pilTind, pilC1::erm, pilC2::cat). (I) MW8 (pilTdud1, pilC2off). (J) MW9 (pilTDQSL, pilC2?—a variant in which PilC2
does not associate with pili).























Given that the suppression of the PilC2 biogenesis defect
occurred in the absence of pilT transcription, we tested whether
restoration of PilT expression would reverse this effect. When
grown in the presence of IPTG strains, MW6 and MW7 behaved
identically to PilC2 strains. The phenotypes manifest in these
strains propagated under pilT-inducing conditions included a
dramatic reduction in Tfp expression (data not shown) and
elaboration of pilin as S-pilin (Fig. 4, lane 5).
Characterization of Piliated, PilC Phase-Off Variants Arising
in pilT Null Mutants. In earlier studies, alleles of pilT that carry
loss-of-function mutations were identified and characterized (18).
These include a frameshift mutation occurring early in the pilT
ORF (the pilTdud1 allele) and an in-frame deletion mutation that
results in the loss of three amino acid residues from the C-
terminal part of the protein (the pilTDQSL allele). Strains bearing
these defective alleles are nontransformable, because of a block
at the level of DNA uptake, making it impossible to introduce
defined pilC mutations into these backgrounds. However, earlier
studies had demonstrated that PilC expression is subject to high
frequency phase variation as a consequence of frameshift muta-
tions within the poly G stretch positioned early in the pilC ORFs
(10, 11). We reasoned that spontaneous PilC2 phase-off mutants
would arise at a readily detectable frequency in these back-
grounds. Colony variants with the same morphology seen for the
piliated, PilC2 knockout mutants were found at frequencies of
'1023 in all of these pilT mutants (Fig. 1 I and J), and, in each
case, these derivatives expressed high levels of Tfp as detected by
TEM (Fig. 2F). Whole cell lysates of such variants arising in
strains GT101 and GT102, bearing the pilTdud1 and pilTDQSL
alleles, respectively, were analyzed in more detail by immuno-
blotting, and, in all but one case, PilC protein was detected at
reduced levels equivalent to the previously characterized pilC
phase-off mutants (Fig. 5A, lanes 3 and 6). Direct nucleotide
sequencing of the early region of the pilC2 ORF in the variants
showed that the reduction of expression resulted from frame-
shifting in the poly G stretch (data not shown). In line with these
observations, variants that displayed the colony morphotype of
their original PilT2 progenitors appeared at frequencies of 1023
in these backgrounds, and, in all cases examined, they regained
high level expression of PilC (data not shown). In the one
exception noted above, a variant isolated in the pilTDQSL back-
FIG. 2. Piliation of gonococcal strains analyzed by transmission electron microscopy. (A) N400 (wild-type). (B) MW4 (pilTind). (C) GT102
(pilTDQSL). (D) MW2 (pilC2::cat). (E) MW7 (pilTind, pilC1::erm, pilC2::cat). (F) MW9 (pilTDQSL, pilC2?). Magnification at 90,0003.
FIG. 3. Quantitative and qualitative analysis of pili purified from
gonococcal strains. (Upper) Immunoblotting of purified pili by using
rabbit antibodies specific for PilC1 and PilC2. (Lower) Coomassie-stained
SDSyPAGE gel showing the relative amounts of pilin subunit in purified
pili. The amounts of samples loaded were equalized based on the total
protein concentration of whole cells. Lanes: 1, N400 (wild-type); 2, MW1
(pilC1::erm); 3, MW2 (pilC2::cat); 4, MW3 (pilC1::erm, pilC2::cat); 5,
MW4 (pilTind); 6, MW5 (pilTind, pilC1::erm); 7, MW6 (pilTind, pilC2::cat);
8, MW7 (pilTind, pilC1::erm, pilC2::cat). With regard to PilC expression,
‘‘1’’ denotes expression, ‘‘off’’ denotes a phase-off allele, and ‘‘2’’ denotes
a knockout mutant. For PilT, ‘‘1’’ denotes wild-type expression while ‘‘2’’
denotes the noninduced pilTind allele.
FIG. 4. Detection of S-pilin, a correlate of a biogenesis defect, in
a PilC2 background requires pilT expression. Shown is immunoblot-
ting of whole cell lysates by using the pilin-specific mAb MC02. Lanes:
1, N400 (wild-type); 2, MW3 (pilC1::erm, pilC2::cat); 3, MW4 (pilTind);
4, MW4 (pilTind); 5, MW7 (pilTind, pilC1::erm, pilC2::cat); 6, MW7
(pilTind, pilC1::erm, pilC2::cat). With regard to PilT expression, in lanes
1 and 2, ‘‘1’’ denotes the wild-type pilT allele; in lanes 3–6, ‘‘1’’
denotes addition of IPTG and ‘‘2’’ denotes no IPTG.























ground (MW9), which had a colony morphology characteristic of
strains having simultaneous defects in pilT and pilC, retained
unaltered levels of immunoblot-detectable PilC2 (Fig. 5A, lane 5).
Examination of protein profiles of pili purified from these
phase variants by staining demonstrated that, in every case, the
only discernible alteration in the variant pili was the absence of
the PilC protein (data not shown). When PilC antisera was used
in immunoblotting of the same samples, a low but clearly repro-
ducible level of PilC protein was seen in these fractions (Fig. 5B,
lanes 3 and 6). Surprisingly, strain MW9, which has a phenotype
similar to the phase-off variants but expressed wild-type levels of
PilC2 in whole cell lysates, contained reduced levels of this
molecule in purified pili (Fig. 5B, lane 5). This finding demon-
strates that the piliated, PilC2-related colony morphology can be
correlated not only with a quantitative defect in PilC expression
but also with the failure of PilC to be associated with purified pili.
Piliated, PilC2 Strains Are Deficient in Human Epithelial Cell
Adherence. Genetically defined mutants expressing Tfp in the
absence of PilC have not been available previously. The isolation
of such strains here made it possible to address directly the
relative contribution of PilC to Tfp-associated adherence for
human epithelial cells. The capacity of derivatives of N400
bearing knockout mutations in pilC2 to adhere to human primary
corneal epithelial cells was dramatically diminished (Fig. 6C; '5
diplococciyepithelial cell for MW2 vs. .100 diplococciyepithelial
cell seen for the wild-type strain). We recovered the adherent
cells seen using MW2 in this assay and found that only 10% of the
colonies arising corresponded to piliated, pilC1 phase-on variants
whereas the rest were identical to the inoculating strain. When
retested, those pilC1 phase-on variants adhered as well to these
epithelial cells as the piliated, pilC2 phase-on strains (data not
shown), confirming that PilC1 and PilC2 are functionally inter-
changeable, not only with respect to Tfp biogenesis but also in
promoting epithelial cell adherence. The pilC1, pilC2 double
knockout mutant strain MW3 adhered at levels below that seen
with the pilC2 knockout (Fig. 6D; ,0.1 diplococcusyepithelial cell
vs. '5 diplococciyepithelial cell), a finding consistent with the
hypothesis that partial pilus biogenesis and adhesive functions can
be imparted by the pilC1 phase-off allele.
Strains with pilT mutations adhere to the human epithelial cell
line ME180 as well as their isogenic wild-type parent, although
they bind in a more localized fashion because of their increased
autoagglutination (18). Virtually identical results were found here
by using the human primary corneal epithelial cells (Fig. 6 E and
G and Table 1). A severe defect in epithelial cell adherence was
found for all piliated strains failing to express functional PilT in
combination with either of the pilC knockout mutations (Fig. 6F)
or the phase-off alleles (data not shown and Table 1), regardless
of the particular combinations of mutations tested. In the strains
using the phase-off pilC alleles, spontaneous variants in which a
phase-on switch in pilC had occurred (identified by virtue of their
PilT2 colony morphology) regained epithelial cell adherence
(data not shown). These findings ruled out the possibility that a
second mutation may have occurred in these backgrounds to
account for the adherence defect.
Given the strong association between PilC and epithelial cell
adherence, we examined the adhesive property of strain MW9,
which expresses both Tfp (Fig. 2F) and PilC2 but in which PilC2
fails to copurify with pili (Fig. 5, lane 5). Despite the presence of
these two components, this strain was as nonadherent for human
primary corneal epithelial cells (Fig. 6H) as the other piliated,
PilC2 mutants (Fig. 6F and Table 1).
DISCUSSION
The ability of most Gram-negative pathogens to colonize mucosal
sites requires the expression of pili. The primary role of these
proteinaceous appendages as colonization factors appears to be
the presentation of adhesive molecules in forms capable of
binding to their specific epithelial cell receptor. The strongest
previous evidence for PilC being the Tfp-associated epithelial cell
adhesin comes from the finding that purified PilC is capable of
competitively blocking the human epithelial cell adherence of
both piliated gonococci and meningococci (12). Here, we found
that genetically defined gonococcal pilT, pilC mutants expressing
high levels of Tfp were incapable of binding to human primary
corneal epithelial cells. These results concur with results obtained
FIG. 5. Quantitative analysis of pili and PilC in pilC2 phase-off
variants arising in pilT null mutants. (A) Immunoblotting of whole cell
lysates using rabbit antibodies specific for PilC1 and PilC2. (B)
Purified pili. (Upper) Immunoblotting using rabbit antibodies specific
for PilC1 and PilC2. (Lower) Coomassie-stained SDSyPAGE gel
showing the relative amounts of pilin subunit. Amounts of pilus
preparations loaded were standardized based on total protein con-
centration of extracted cells. Lanes: 1, N400 (wild-type); 2, GT101
(pilTdud1); 3, MW8 (pilTdud1, pilC2off); 4, GT102 (pilTDQSL); 5, MW9
(pilTDQSL, pilC2?); 6, MW10 (pilTDQSL, pilC2off); 7, MW3 (pilC1::erm,
pilC2::cat); 8, MW7 (pilTind, pilC1::erm, pilC2::cat). Note that strain
MW9 (lane 5) expresses wild-type levels of PilC2 antigen in whole cell
lysates but has reduced amounts in purified pili and has a PilT2, PilC2
phenotype. Strains MW3 and MW7 (lanes 7 and 8) are pilC1, pilC2
double-knockout mutants whereas all other strains used carry the
pilC1 phase-off allele.
FIG. 6. Adherence of genetically defined gonococcal mutants and variants for human corneal epithelial cells. Adherent gonococci are stained
with crystal violet. (A) N400 (wild-type). (B) MW1 (pilC1::erm). (C) MW2 (pilC2::cat). (D) MW3 (pilC1::erm, pilC2::cat). (E) MW4 (pilTind). (F)
MW7 (pilTind, pilC1::erm, pilC2::cat). (G) GT102 (pilTDQSL). (H) MW9 (pilTDQSL, pilC2?).























by using a piliated pilC mutant that was reported to carry at least
one and perhaps two other uncharacterized mutations that were
responsible for suppression of the pilC biogenesis defect (11). All
pilT mutants characterized here adhered quantitatively as well, if
not better, to human epithelial cells than to wild-type cells.
Therefore, PilC appears to function as an adhesin under condi-
tions in which it is not required for biogenesis. Nonetheless, its
ability to function as an adhesin appears to correlate with its
capacity to associate with Tfp as evidenced by the adherence
defect of the mutant that expresses Tfp and wild-type levels of
PilC2 protein but in which PilC2 fails to copurify with pili. Future
studies should determine whether this mutant carries a mutation
in pilC2 or in a second gene whose product is required for PilC
to associate with Tfp. This particular class of mutant also dem-
onstrates how strains lacking PilT provide a unique background
in which to probe the relationships between the structure of PilC
proteins and their capacity to function as Tfp-associated adhesins.
It was surprising that, when expression of PilC2 was blocked by
gene disruption in a pilT background, low levels of PilC antigen
still could be detected by immunoblotting purified Tfp. Low levels
of PilC antigen also were seen in whole cell lysates and purified
Tfp from the strains in which both pilC alleles were in their
phase-off configuration. The simplest explanation would be that
this PilC antigen reflects the presence of phase-on variants within
the cell population. However, the frequencies with which
phase-on variants arise (1023) is too low to account for the levels
of PilC antigen seen (data not shown). We believe this PilC
antigen represents polypeptide translated from the out-of-frame
mRNA caused by ribosomal frameshifting. A similar phenome-
non in which functional levels of gene product are expressed from
an out-of-frame allele has been observed for the N. gonorrhoeae
lsi2 gene, which also contains a poly G stretch in its ORF (26).
Regardless of the basis for this phenomenon, Tfp purified from
pilT mutants with phase-off pilC alleles contains low levels of PilC
antigen, and those strains adhere poorly to human epithelial
tissue but at levels higher than that found for the pilC double-
knockout mutants. This may indicate that a certain threshold
level of PilC associated with Tfp needs to be achieved in order for
efficient adherence. Alternatively, the PilC found with purified
Tfp in these backgrounds may not promote adherence because it
is not displayed properly or associated with Tfp in the same
manner as in the strains expressing high levels of adherence.
Although it is now clear through studies of P. aeruginosa, M.
xanthus, and N. gonorrhoeae that Tfp expression is required for
twitching motility, the molecular basis for these associations
remains unknown. Studies in all three species have shown that Tfp
are necessary, but not sufficient, for this property because, in a
remarkable convergence of findings, piliated but nonmotile mu-
tants in all three species have been found to carry loss-of-function
mutations in pilT. Here, we provide direct evidence that gono-
coccal PilT influences the Tfp biogenesis pathway as assessed by
the genetic suppression of the defect in pilC mutants when
functional PilT is absent. Viewed in a slightly different way, these
findings show that pilC mutants are deficient in Tfp expression
because they express PilT.
The isolation of extragenic suppresser mutations often implies
that the products of the two genes either interact with one another
or act on a common pathway. PilC is reported to localize to the
outer membrane (27) as well as to Tfp fibers (12) whereas
gonococcal PilT has been shown to be localized to the cytoplasm
and the inner membrane (28). Although one must interpret
protein localization findings with caution, it seems likely that
these molecules do not interact directly with one another. The fact
that loss of PilT function suppresses the pilC defect appears to
indicate that the two molecules have antagonistic effects on Tfp
biogenesis. Although the role of PilC in biogenesis is not under-
stood, the following observations may relate to its function. First,
gonococcal mutants lacking functional PilQ, the secretin family
member that, in its multimeric form, appears to act as the outer
membrane channel for Tfp biogenesis, shed PilC into the extra-
cellular milieu (29). Second, immunogold labeling has been
interpreted as indicating that PilC colocalizes with Tfp filaments
(12). As such, we propose that PilC functions as a biogenesis
factor by virtue of its physical association with Tfp. Specifically,
we envision that PilC acts either as an initiator of Tfp fiber
extrusion or as a chaperone for Tfp as they are formed. Twitching
motility has been proposed to be a consequence of pilus retrac-
tion (15), but, for technical reasons, direct evidence for this
possibility is lacking. Still, the retraction hypothesis suggests a
mechanism for the findings presented here as follows: Tfp
formation occurs in the absence of PilC, but those pili are not
stabilized and are retracted rapidly. Suppression of the pilus
biogenesis defect in pilC mutants might then result from a defect
in the retraction step because of loss-of-function mutations in
pilT. Although speculative, this scenario lends itself to a number
of testable hypotheses based on the notion that PilC and PilT have
counteractive effects on Tfp biogenesisyextrusion that lead to the
phenomenon of twitching motility.
In summary, we have demonstrated that the PilT protein
influences the gonococcal Tfp biogenesis pathway and have
provided evidence that Tfp biogenesis is a dynamic process. Given
that gonococcal PilT is required for DNA uptake during genetic
transformation and twitching motility, these results provide a link
for how PilT expression might physically influence these pro-
cesses. In addition to the potential relevance to studies of twitch-
ing motility in other species, this gonococcal system may provide
insights into the Type II protein secretion pathway of Gram-
negatives and the gene transfer systems of both Gram-negative
and Gram-positive species, which use a high-related set of com-
ponents.
We thank Alexey Merz in the So laboratory, Oregon Health Sciences
University, Portland, OR for providing the MS11 pilC knockout alleles.
Human corneas were generously provided by Dr. P. Buck, Montana Eye
Bank, Missoula, MT. This work was supported by Public Health Service
Grant A127837 (to M.K.) and National Institutes of Health Clinical
Research Center grant M01 RR 00042.
1. Hultgren, S. J., Abraham, S., Caparon, M., Falk, P., St. Geme, J. W. &
Normark, S. (1993) Cell 73, 887–901.
2. Strom, M. S. & Lory, S. (1993) Annu. Rev. Microbiol. 47, 565–596.
3. Parge, H. E., Forest, K. T., Hickey, M. J., Christensen, D. A., Getzoff, E. D.
& Tainer, J. A. (1995) Nature (London) 378, 32–38.
4. Tønjum, T. & Koomey, M. (1997) Gene 192, 155–163.
5. Pugsley, A. P. (1993) Microbiol. Rev. 57, 50–108.
6. Dubnau, D. (1997) Gene 192, 191–198.
7. Russel, M., Linderoth, N. A. & Sali, A. (1997) Gene 192, 23–32.
8. Lory, S. & Strom, M. S. (1997) Gene 192, 117–121.
9. Swanson, J. (1973) J. Exp. Med. 137, 571–589.
10. Jonsson, A. B., Nyberg, G. & Normark, S. (1991) EMBO J. 10, 477–488.
11. Rudel, T., van Putten, J. P. M., Gibbs, C. P., Hass, R. & Meyer, T. F. (1992)
Mol. Microbiol. 6, 3439–3450.
12. Rudel, T., Scheurerpflug, I. & Meyer, T. F. (1995) Nature (London) 373,
357–359.
13. Swanson, J. (1978) Infect. Immun. 19, 320–331.
14. Henrichsen, J. (1983) Annu. Rev. Microbiol. 37, 81–93.
15. Bradley, D. E. (1980) Can. J. Microbiol. 26, 146–154.
16. Wu, S. & Kaiser, D. (1995) Mol. Microbiol. 18, 547–558.
17. Wu, S., Wu, J. & Kaiser, D. (1997) Mol. Microbiol. 23, 109–121.
18. Wolfgang, M., Lauer, P., Park, H.-S., Brossay, L., Hebert, J. & Koomey, M.
(1998) Mol. Microbiol. 29, 321–330.
19. Whitchurch, C. B., Hobbs, M., Livingston, S. P., Krishnapillai, V. &
Mattick, J. S. (1991) Gene 101, 33–44.
20. Lessl, M. & Lanka, E. (1994) Cell 77, 321–324.
21. Freitag, N., Seifert, H. S. & Koomey, M. (1995) Mol. Microbiol. 16, 575–586.
22. Seifert, H. (1997) Gene 188, 215–220.
23. Koomey, M., Bergstrom, S., Blake, M. & Swanson, J. (1991) Mol. Microbiol.
5, 279–287.
24. Tønjum, T., Freitag, N. E., Normark, E. & Koomey, M. (1995) Mol.
Microbiol. 16, 451–464.
25. van Putten, J. P. M. & Paul, S. M. (1995) EMBO J. 14, 2144–2154.
26. Burch, C. L., Danaher, R. J. & Stein, D. C. (1997) J. Bacteriol. 179, 982–986.
27. Rahman, M., Kallstrom, H., Normark, S. & Jonsson, A.-B. (1997) Mol.
Microbiol. 25, 11–26.
28. Brossay, L., Paradis, G., Fox, R., Koomey, M. & Hebert, J. (1994) Infect.
Immun. 62, 2302–2308.
29. Drake, S. L., Sandstedt, S. A. & Koomey, M. (1996) Mol. Microbiol. 23,
657–668.
14978 Microbiology: Wolfgang et al. Proc. Natl. Acad. Sci. USA 95 (1998)
D
ow
nl
oa
de
d 
by
 g
ue
st
 o
n 
S
ep
te
m
be
r 
11
, 2
02
0 
